Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus G3P antigen refers to the outer capsid proteins of the Rotavirus, specifically the VP7 glycoprotein (G3 serotype) and the VP4 protease-sensitive protein (P genotype) [1]. These proteins are critical for the virus's life cycle: VP4 facilitates initial attachment to host cell receptors and membrane penetration, while VP7 forms the outer shell and mediates the final stages of viral entry [4]. As the most prominent surface features of the virion, they are the primary targets for neutralizing antibodies (IgA and IgG) elicited during natural infection or vaccination [1]. Vaccines such as RotaTeq and Rotasiil specifically incorporate G3 antigens to provide broad protection against this common cause of severe pediatric gastroenteritis [3]. Targeting these antigens has been a cornerstone of global public health efforts to reduce the burden of diarrheal disease in infants [5].
Induction of neutralizing antibodies (IgA and IgG) that block viral attachment and entry into enterocytes [1, 4].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus Outer Capsid Protein VP7 (G3) and VP4 (P) (VP7/VP4 (G3P)).